Unity in diversity: Shared mechanism of entry among paramyxoviruses

Progress in Molecular Biology and Translational Science

Volumn 129, Issue , 2015, Pages 1-32

  Palgen, Jean Louis ^a,b   Jurgens, Eric M ^a   Moscona, Anne ^a   Porotto, Matteo ^a   Palermo, Laura M ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Fusion machinery; Fusion protein; Paramyxoviridae; Receptor binding protein; Viral entry

Indexed keywords

GLYCOPROTEIN; HYBRID PROTEIN; PARAMYXOVIRUS GLYCOPROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; CELL SURFACE RECEPTOR; PROTEIN BINDING;

HYDROPHOBICITY; LIFE CYCLE; MICROBIAL DIVERSITY; NATURAL HOST; NONHUMAN; PARAMYXOVIRIDAE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS MORPHOLOGY; ANIMAL; CHEMISTRY; CLASSIFICATION; HUMAN; METABOLISM; PHYSIOLOGY;

ANIMALS; GLYCOPROTEINS; HUMANS; PARAMYXOVIRIDAE; PROTEIN BINDING; RECEPTORS, CELL SURFACE; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84920836542     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/bs.pmbts.2014.10.001     Document Type: Chapter

References (144)

1. Chang A, Dutch RE. Paramyxovirus fusion and entry: multiple paths to a common end. Viruses. 2012;4(4):613-636. http://dx.doi.org/10.3390/v4040613.
2. Enders G. Paramyxoviruses. In: Baron S, ed. Medical Microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch at Galveston; 1996 Available at, http://www.ncbi.nlm.nih.gov/books/NBK8461/, Accessed April 11, 2014.
3. Bossart KN, Fusco DL, Broder CC. Paramyxovirus entry. Adv Exp Med Biol. 2013;790:95-127. http://dx.doi.org/10.1007/978-1-4614-7651-1-6.
4. Falk K, Batts WN, Kvellestad A, Kurath G, Wiik-Nielsen J, Winton JR. Molecular characterisation of Atlantic salmon paramyxovirus (ASPV): a novel paramyxovirus associated with proliferative gill inflammation. Virus Res. 2008;133(2):218-227. http://dx.doi.org/10.1016/j.virusres.2008.01.006.
5. Kurath G, Batts WN, Ahne W, Winton JR. Complete genome sequence of Fer-de-Lance virus reveals a novel gene in reptilian paramyxoviruses. J Virol. 2004;78(4):2045-2056.
6. Ganar K, Das M, Sinha S, Kumar S. Newcastle disease virus: current status and our understanding. Virus Res. 2014;184C:71-81. http://dx.doi.org/10.1016/j.virusres.2014.02.016.
7. Croser EL, Marsh GA. The changing face of the henipaviruses. Vet Microbiol. 2013;167(1-2):151-158. http://dx.doi.org/10.1016/j.vetmic.2013.08.002.
8. Kurth A, Kohl C, Brinkmann A, et al. Novel paramyxoviruses in free-ranging European bats. PLoS One. 2012;7(6):e38688. http://dx.doi.org/10.1371/journal.pone.0038688.
9. Marsh GA, de Jong C, Barr JA, et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog. 2012;8(8):e1002836. http://dx.doi.org/10.1371/journal.ppat.1002836.
10. Magoffin DE, Mackenzie JS, Wang L-F. Genetic analysis of J-virus and Beilong virus using minireplicons. Virology. 2007;364(1):103-111. http://dx.doi.org/10.1016/j.virol.2007.01.045.
11. Weinberg GA, Hall CB, Iwane MK, et al. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. 2009;154(5):694-699. http://dx.doi.org/10.1016/j.jpeds.2008.11.034.
12. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and metaanalysis. Lancet. 2010;375(9725):1545-1555. http://dx.doi.org/10.1016/S0140-6736(10)60206-1.
13. Williams JV, Tollefson SJ, Heymann PW, Carper HT, Patrie J, Crowe JE. Human metapneumovirus infection in children hospitalized for wheezing. J Allergy Clin Immunol . 2005;115(6):1311-1312. http://dx.doi.org/10.1016/j.jaci.2005.02.001.
14. Clayton BA, Wang LF, Marsh GA. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission. Zoonoses Public Health. 2013;60(1):69-83. http://dx.doi.org/10.1111/j.1863-2378.2012.01501.x.
15. Kumaria R, Iyer LR, Hibberd ML, Simões EAF, Sugrue RJ. Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children. Virol J 2011; 8: 372. http://dx.doi.org/10.1186/1743-422X-8-372.
16. Takeuchi K, Miyajima N, Kobune F, Tashiro M. Comparative nucleotide sequence analyses of the entire genomes of B95a cell-isolated and vero cell-isolated measles viruses from the same patient. Virus Genes. 2000; 20(3): 253-257.
17. Lo MK, Harcourt BH, Mungall BA, et al. Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells. J Gen Virol. 2009; 90(Pt 2): 398-404. http://dx.doi.org/10.1099/vir.0.007294-0.
18. Yu M, Hansson E, Langedijk JP, Eaton BT, Wang LF. The attachment protein of Hendra virus has high structural similarity but limited primary sequence homology compared with viruses in the genus Paramyxovirus. Virology. 1998; 251(2): 227-233. http://dx.doi.org/10.1006/viro.1998.9302.
19. Jack PJM, Boyle DB, Eaton BT, Wang L-F. The complete genome sequence of J virus reveals a unique genome structure in the family Paramyxoviridae. J Virol. 2005; 79(16): 10690-10700. http://dx.doi.org/10.1128/JVI.79.16.10690-10700.2005.
20. Li Z, Yu M, Zhang H, et al. Beilong virus, a novel paramyxovirus with the largest genome of non-segmented negative-stranded RNA viruses. Virology. 2006; 346(1): 219-228. http://dx.doi.org/10.1016/j.virol.2005.10.039.
21. Hausmann S, Jacques JP, Kolakofsky D. Paramyxovirus RNA editing and the requirement for hexamer genome length. RNA. 1996; 2(10): 1033-1045.
22. Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA. Nipah virus conforms to the rule of six in a minigenome replication assay. J Gen Virol. 2004; 85(pt 3): 701-707.
23. Jin H, Zhou H, Cheng X, Tang R, Munoz M, Nguyen N. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology. 2000; 273(1): 210-218. http://dx.doi.org/10.1006/viro.2000.0393.
24. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology. 1996; 225(1): 156-162. http://dx.doi.org/10.1006/viro.1996.0583.
25. He B, Leser GP, Paterson RG, Lamb RA. The paramyxovirus SV5 small hydrophobic (SH) protein is not essential for virus growth in tissue culture cells. Virology. 1998; 250(1): 30-40. http://dx.doi.org/10.1006/viro.1998.9354.
26. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol. 2005; 79(19): 12608-12613. http://dx.doi.org/10.1128/JVI.79.19.12608-12613.2005.
27. Atreya PL, Peeples ME, Collins PL. The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication. J Virol. 1998; 72(2): 1452-1461.
28. Audsley MD, Moseley GW. Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol. 2013;2(2): 57-70. http://dx.doi.org/10.5501/wjv.v2.i2.57.
29. Huberman K, Peluso RW, Moscona A. Hemagglutinin-neuraminidase of human parainfluenza 3: role of the neuraminidase in the viral life cycle. Virology. 1995; 214(1): 294-300. http://dx.doi.org/10.1006/viro.1995.9925.
30. Moscona A, Peluso RW. Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J Virol . 1991; 65(6): 2773-2777.
31. Morrison T, McQuain C, McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol. 1991; 65(2): 813-822.
32. Moscona A, Peluso RW. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity. J Virol. 1993; 67(11): 6463-6468.
33. Navaratnarajah CK, Oezguen N, Rupp L, et al. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol. 2011; 18(2): 128-134. http://dx.doi.org/10.1038/nsmb.1967.
34. Mirza AM, Aguilar HC, Zhu Q, et al. Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptors. J Biol Chem. 2011; 286(20): 17851-17860. http://dx.doi.org/10.1074/jbc.M111.233965.
35. Corey EA, Iorio RM. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J Virol. 2007; 81(18): 9900-9910. http://dx.doi.org/10.1128/JVI.00909-07.
36. Aguilar HC, Matreyek KA, Filone CM, et al. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol. 2006; 80(10): 4878-4889. http://dx.doi.org/10.1128/JVI.80.10.4878-4889.2006.
37. Bishop KA, Hickey AC, Khetawat D, et al. Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. J Virol. 2008; 82(22): 11398-11409. http://dx.doi.org/10.1128/JVI.02654-07.
38. Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R. Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol. 2002; 76(10): 5051-5061.
39. Iorio RM, Melanson VR, Mahon PJ. Glycoprotein interactions in paramyxovirus fusion. Future Virol. 2009; 4(4): 335-351. http://dx.doi.org/10.2217/fvl.09.17.
40. Lee B, Ataman ZA. Modes of paramyxovirus fusion: a Henipavirus perspective. Trends Microbiol. 2011; 19(8): 389-399. http://dx.doi.org/10.1016/j.tim.2011.03.005.
41. Iorio RM, Mahon PJ. Paramyxoviruses: different receptors-different mechanisms of fusion. Trends Microbiol. 2008; 16(4): 135-137. http://dx.doi.org/10.1016/j.tim.2008.01.006.
42. Porotto M, Murrell M, Greengard O, Doctor L, Moscona A. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J Virol. 2005; 79(4): 2383-2392. http://dx.doi.org/10.1128/JVI.79.4.2383-2392.2005.
43. Porotto M, Murrell M, Greengard O, Moscona A. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion. J Virol. 2003; 77(6): 3647-3654.
44. Dutch RE. Entry and fusion of emerging paramyxoviruses. PLoS Pathog. 2010; 6(6): e1000881. http://dx.doi.org/10.1371/journal.ppat.1000881.
45. Plattet P, Plemper RK. Envelope protein dynamics in paramyxovirus entry. MBio. 2013;4(4): e00413. http://dx.doi.org/10.1128/mBio.00413-13.
46. Porotto M, Devito I, Palmer SG, et al. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J Virol . 2011; 85(24): 12867-12880. http://dx.doi.org/10.1128/JVI.05873-11.
47. Porotto M, Palmer SG, Palermo LM, Moscona A. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. J Biol Chem. 2012;287(1): 778-793. http://dx.doi.org/10.1074/jbc.M111.298059.
48. Yuan P, Swanson KA, Leser GP, Paterson RG, Lamb RA, Jardetzky TS. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci USA. 2011; 108(36): 14920-14925. http://dx.doi.org/10.1073/pnas.1111691108.
49. Bose S, Welch BD, Kors CA, Yuan P, Jardetzky TS, Lamb RA. Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol. 2011; 85(24): 12855-12866. http://dx.doi.org/10.1128/JVI.06350-11.
50. Colf LA, Juo ZS, Garcia KC. Structure of the measles virus hemagglutinin. Nat Struct Mol Biol. 2007; 14(12): 1227-1228. http://dx.doi.org/10.1038/nsmb1342.
51. Hashiguchi T, Kajikawa M, Maita N, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci USA. 2007; 104(49): 19535-19540. http://dx.doi.org/10.1073/pnas.0707830104.
52. Hashiguchi T, Ose T, Kubota M, et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol. 2011; 18(2): 135-141. http://dx.doi.org/10.1038/nsmb.1969.
53. Bowden TA, Aricescu AR, Gilbert RJC, Grimes JM, Jones EY, Stuart DI. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol. 2008; 15(6): 567-572. http://dx.doi.org/10.1038/nsmb.1435.
54. Xu K, Rajashankar KR, Chan Y-P, Himanen JP, Broder CC, Nikolov DB. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci USA. 2008; 105(29): 9953-9958. http://dx.doi.org/10.1073/pnas.0804797105.
55. Welch BD, Yuan P, Bose S, Kors CA, Lamb RA, Jardetzky TS. Structure of the parainfluenza virus 5 (PIV5) hemagglutinin-neuraminidase (HN) ectodomain. PLoS Pathog 2013; 9(8): e1003534. http://dx.doi.org/10.1371/journal.ppat.1003534.
56. Lawrence MC, Borg NA, Streltsov VA, et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol. 2004; 335(5): 1343-1357.
57. Navaratnarajah CK, Negi S, Braun W, Cattaneo R. Membrane fusion triggering: three modules with different structure and function in the upper half of the measles virus attachment protein stalk. J Biol Chem. 2012;287(46): 38543-38551. http://dx.doi.org/10.1074/jbc.M112.410563.
58. Navaratnarajah CK, Kumar S, Generous A, Apte-Sengupta S, Mateo M, Cattaneo R. The measles virus hemagglutinin stalk: structure and function of the central fusionactivation and membrane-proximal segments. J Virol. 2014;88(11): 6158-6167. http://dx.doi.org/10.1128/JVI.02846-13.
59. Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI. Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol. 2010; 84(12): 6208-6217. http://dx.doi.org/10.1128/JVI.00317-10.
60. Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000; 7(11): 1068-1074. http://dx.doi.org/10.1038/81002.
61. Santiago C, Celma ML, Stehle T, Casasnovas JM. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol. 2010; 17(1): 124-129. http://dx.doi.org/10.1038/nsmb.1726.
62. Zaitsev V, von Itzstein M, Groves D, et al. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol. 2004; 78(7): 3733-3741.
63. Bousse TL, Taylor G, Krishnamurthy S, Portner A, Samal SK, Takimoto T. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J Virol. 2004; 78(23): 13351-13355. http://dx.doi.org/10.1128/JVI.78.23.13351-13355.2004.
64. Porotto M, Salah Z, DeVito I, et al. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J Virol. 2012;86(10): 5730-5741. http://dx.doi.org/10.1128/JVI.06793-11.
65. Bousse T, Takimoto T. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. J Virol. 2006; 80(18): 9009-9016. http://dx.doi.org/10.1128/JVI.00969-06.
66. Alymova IV, Portner A, Mishin VP, McCullers JA, Freiden P, Taylor GL. Receptorbinding specificity of the human parainfluenza virus type 1 hemagglutininneuraminidase glycoprotein. Glycobiology . 2012;22(2): 174-180. http://dx.doi.org/10.1093/glycob/cwr112.
67. Porotto M, Fornabaio M, Kellogg GE, Moscona A. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J Virol. 2007; 81(7): 3216-3228. http://dx.doi.org/10.1128/JVI.02617-06.
68. Leonard VH, Sinn PL, Hodge G, et al. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest. 2008; 118: 2448-2458.
69. Welch BD, Liu Y, Kors CA, Leser GP, Jardetzky TS, Lamb RA. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci USA. 2012;109(41): 16672-16677. http://dx.doi.org/10.1073/pnas.1213802109.
70. Yin H-S, Paterson RG, Wen X, Lamb RA, Jardetzky TS. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci USA. 2005; 102(26): 9288-9293. http://dx.doi.org/10.1073/pnas.0503989102.
71. Smith EC, Smith SE, Carter JR, et al. Trimeric transmembrane domain interactions in paramyxovirus fusion proteins: roles in protein folding, stability, and function. J Biol Chem. 2013;288(50): 35726-35735. http://dx.doi.org/10.1074/jbc.M113.514554.
72. Smith EC, Culler MR, Hellman LM, Fried MG, Creamer TP, Dutch RE. Beyond anchoring: the expanding role of the hendra virus fusion protein transmembrane domain in protein folding, stability, and function. J Virol. 2012;86(6): 3003-3013. http://dx.doi.org/10.1128/JVI.05762-11.
73. González-Reyes L, Ruiz-Argüello MB, García-Barreno B, et al. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci USA. 2001; 98(17): 9859-9864. http://dx.doi.org/10.1073/pnas.151098198.
74. Diederich S, Moll M, Klenk H-D, Maisner A. The nipah virus fusion protein is cleaved within the endosomal compartment. J Biol Chem. 2005; 280(33): 29899-29903. http://dx.doi.org/10.1074/jbc.M504598200.
75. Pager CT, Dutch RE. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol. 2005; 79(20): 12714-12720. http://dx.doi.org/10.1128/JVI.79.20.12714-12720.2005.
76. Pager CT, Craft Jr WW, Patch J, Dutch RE. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology. 2006; 346(2): 251-257. http://dx.doi.org/10.1016/j.virol.2006.01.007.
77. Diederich S, Sauerhering L, Weis M, et al. Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment. J Virol. 2012;86(7): 3736-3745. http://dx.doi.org/10.1128/JVI.06628-11.
78. Smith EC, Gregory SM, Tamm LK, Creamer TP, Dutch RE. Role of sequence and structure of the Hendra fusion protein fusion peptide in membrane fusion. J Biol Chem. 2012;287(35): 30035-30048. http://dx.doi.org/10.1074/jbc.M112.367862.
79. Kim YH, Donald JE, Grigoryan G, et al. Capture and imaging of a prehairpin fusion intermediate of the paramyxovirus PIV5. Proc Natl Acad Sci USA. 2011; 108(52): 20992-20997. http://dx.doi.org/10.1073/pnas.1116034108.
80. Yin H-S, Wen X, Paterson RG, Lamb RA, Jardetzky TS. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature. 2006; 439(7072): 38-44. http://dx.doi.org/10.1038/nature04322.
81. McLellan JS, Yang Y, Graham BS, Kwong PD. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol. 2011; 85(15): 7788-7796. http://dx.doi.org/10.1128/JVI.00555-11.
82. Swanson K, Wen X, Leser GP, Paterson RG, Lamb RA, Jardetzky TS. Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology. 2010; 402(2): 372-379. http://dx.doi.org/10.1016/j.virol.2010.03.050.
83. Harrison SC. Viral membrane fusion. Nat Struct Mol Biol. 2008; 15(7): 690-698. http://dx.doi.org/10.1038/nsmb.1456.
84. Biering SB, Huang A, Vu AT, et al. N-Glycans on the Nipah virus attachment glycoprotein modulate fusion and viral entry as they protect against antibody neutralization. J Virol . 2012;86(22): 11991-12002. http://dx.doi.org/10.1128/JVI.01304-12.
85. Dörig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993; 75(2): 295-305.
86. Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 2000; 406(6798): 893-897. http://dx.doi.org/10.1038/35022579.
87. Erlenhoefer C, Wurzer WJ, Löffler S, Schneider-Schaulies S, ter Meulen V, Schneider- Schaulies J. CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol. 2001; 75(10): 4499-4505. http://dx.doi.org/10.1128/JVI.75.10.4499-4505.2001.
88. Noyce RS, Bondre DG, Ha MN, et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog . 2011; 7(8): e1002240. http://dx.doi.org/10.1371/journal.ppat.1002240.
89. Mühlebach MD, Mateo M, Sinn PL, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature. 2011; 480(7378): 530-533. http://dx.doi.org/10.1038/nature10639.
90. Kato S-I, Nagata K, Takeuchi K. Cell tropism and pathogenesis of measles virus in monkeys. Front Microbiol . 2012; 3: 14. http://dx.doi.org/10.3389/fmicb.2012.00014.
91. Bonaparte MI, Dimitrov AS, Bossart KN, et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci USA. 2005; 102(30): 10652-10657. http://dx.doi.org/10.1073/pnas.0504887102.
92. Mathieu C, Pohl C, Szecsi J, et al. Nipah virus uses leukocytes for efficient dissemination within a host. J Virol. 2011; 85(15): 7863-7871. http://dx.doi.org/10.1128/JVI.00549-11.
93. Krusat T, Streckert HJ. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol. 1997; 142(6): 1247-1254.
94. Bourgeois C, Bour JB, Lidholt K, Gauthray C, Pothier P. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro. J Virol. 1998; 72(9): 7221-7227.
95. Feldman SA, Hendry RM, Beeler JA. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol. 1999; 73(8): 6610-6617.
96. Thammawat S, Sadlon TA, Hallsworth PG, Gordon DL. Role of cellular glycosaminoglycans and charged regions of viral Gprotein in human metapneumovirus infection. J Virol. 2008; 82(23): 11767-11774. http://dx.doi.org/10.1128/JVI.01208-08.
97. Harcourt JL, Karron RA, Tripp RA. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis. J Infect Dis. 2004; 190(11): 1936-1940. http://dx.doi.org/10.1086/425516.
98. Chirkova T, Boyoglu-Barnum S, Gaston KA, et al. Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses. J Virol. 2013;87(24): 13466-13479. http://dx.doi.org/10.1128/JVI.01741-13.
99. Steffen DL, Xu K, Nikolov DB, Broder CC. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses. 2012;4(2): 280-308. http://dx.doi.org/10.3390/v4020280.
100. Russell CJ, Jardetzky TS, Lamb RA. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J. 2001; 20(15): 4024-4034. http://dx.doi.org/10.1093/emboj/20.15.4024.
101. Bose S, Zokarkar A, Welch BD, Leser GP, Jardetzky TS, Lamb RA. Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc Natl Acad Sci USA. 2012;109(39): E2625-E2634. http://dx.doi.org/10.1073/pnas.1213813109.
102. Liu Q, Stone JA, Bradel-Tretheway B, et al. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry. PLoS Pathog. 2013;9(11): e1003770. http://dx.doi.org/10.1371/journal.ppat.1003770.
103. Ader N, Brindley MA, Avila M, et al. Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion. J Biol Chem. 2012;287(20): 16324-16334. http://dx.doi.org/10.1074/jbc.M112.342493.
104. Brindley MA, Suter R, Schestak I, Kiss G, Wright ER, Plemper RK. A stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion. J Virol. 2013;87(21): 11693-11703. http://dx.doi.org/10.1128/JVI.01945-13.
105. Talekar A, Moscona A, Porotto M. Measles fusion machinery activated by sialic acid binding globular domain. J Virol. 2013;87(24): 13619-13627. http://dx.doi.org/10.1128/JVI.02256-13.
106. Melanson VR, Iorio RM. Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol. 2004; 78(23): 13053-13061. http://dx.doi.org/10.1128/JVI.78.23.13053-13061.2004.
107. Bose S, Song AS, Jardetzky TS, Lamb RA. Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells. J Virol. 2014;88(8): 3925-3941. http://dx.doi.org/10.1128/JVI.03741-13.
108. Xu R, Palmer SG, Porotto M, et al. Interaction between the Hemagglutinin-neuraminidase and fusion glycoproteins of human parainfluenza virus type III regulates viral growth in vivo. MBio. 2013;4(5): e00803-e00813. http://dx.doi.org/10.1128/mBio.00803-13.
109. Bossart KN, Wang L-F, Flora MN, et al. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. J Virol. 2002; 76(22): 11186-11198.
110. Ader N, Brindley M, Avila M, et al. Mechanism for active membrane fusion triggering by morbillivirus attachment protein. J Virol . 2013;87(1): 314-326. http://dx.doi.org/10.1128/JVI.01826-12.
111. Porotto M, Salah ZW, Gui L, et al. Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state. J Virol. 2012;86(23): 12838-12848. http://dx.doi.org/10.1128/JVI.01965-12.
112. Cantín C, Holguera J, Ferreira L, Villar E, Muñoz-Barroso I. Newcastle disease virus may enter cells by caveolae-mediated endocytosis. J Gen Virol. 2007; 88(pt 2): 559-569. http://dx.doi.org/10.1099/vir.0.82150-0.
113. Schowalter RM, Chang A, Robach JG, Buchholz UJ, Dutch RE. Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J Virol. 2009; 83(3): 1511-1522. http://dx.doi.org/10.1128/JVI.01381-08.
114. Kolokoltsov AA, Deniger D, Fleming EH, Roberts Jr NJ, Karpilow JM, Davey RA. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol. 2007; 81(14): 7786-7800. http://dx.doi.org/10.1128/JVI.02780-06.
115. Diederich S, Thiel L, Maisner A. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology. 2008; 375(2): 391-400. http://dx.doi.org/10.1016/j.virol.2008.02.019.
116. Sánchez-Felipe L, Villar E, Muñoz-Barroso I. Entry of Newcastle disease virus into the host cell: role of acidic pH and endocytosis. Biochim Biophys Acta. 2013; 1838(1 pt B): 300-309. http://dx.doi.org/10.1016/j.bbamem.2013.08.008.
117. Kahn JS, Schnell MJ, Buonocore L, Rose JK. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 1999; 254(1): 81-91. http://dx.doi.org/10.1006/viro.1998.9535.
118. Techaarpornkul S, Barretto N, Peeples ME. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J Virol. 2001; 75(15): 6825-6834. http://dx.doi.org/10.1128/JVI.75.15.6825-6834.2001.
119. Schowalter RM, Smith SE, Dutch RE. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol. 2006; 80(22): 10931-10941. http://dx.doi.org/10.1128/JVI.01287-06.
120. Sergel TA, McGinnes LW, Morrison TG. A single amino acid change in the Newcastle disease virus fusion protein alters the requirement for HN protein in fusion. J Virol. 2000; 74(11): 5101-5107.
121. Seth S, Vincent A, Compans RW. Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J Virol. 2003; 77(1): 167-178.
122. Ito M, Nishio M, Kawano M, Komada H, Ito Y, Tsurudome M. Effects of multiple amino acids of the parainfluenza virus 5 fusion protein on its haemagglutinin-neuraminidase-independent fusion activity. J Gen Virol. 2009; 90(pt 2): 405-413. http://dx.doi.org/10.1099/vir.0.006437-0.
123. Karron RA, Buonagurio DA, Georgiu AF, et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci USA. 1997; 94(25): 13961-13966.
124. Dutch RE, Joshi SB, Lamb RA. Membrane fusion promoted by increasing surface densities of the paramyxovirus F and HN proteins: comparison of fusion reactions mediated by simian virus 5 F, human parainfluenza virus type 3 F, and influenza virus HA. J Virol. 1998; 72(10): 7745-7753.
125. Herfst S, Mas V, Ver LS, et al. Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J Virol. 2008; 82(17): 8891-8895. http://dx.doi.org/10.1128/JVI.00472-08.
126. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med. 2011; 17(9): 1132-1135. http://dx.doi.org/10.1038/nm.2444.
127. Wei Y, Zhang Y, Cai H, et al. Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f ) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol. 2014;88(8): 4338-4352. http://dx.doi.org/10.1128/JVI.03491-13.
128. Feldman SA, Audet S, Beeler JA. The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate. J Virol. 2000; 74(14): 6442-6447.
129. Barretto N, Hallak LK, Peeples ME. Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection. Virology. 2003; 313(1): 33-43.
130. Chang A, Masante C, Buchholz UJ, Dutch RE. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol. 2012;86(6): 3230-3243. http://dx.doi.org/10.1128/JVI.06706-11.
131. Talekar A, DeVito I, Salah Z, et al. Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation. J Virol. 2013;87(20): 10980-10996. http://dx.doi.org/10.1128/JVI.01646-13.
132. Bose S, Heath CM, Shah PA, Alayyoubi M, Jardetzky TS, Lamb RA. Mutations in the parainfluenza virus 5 fusion (F) protein reveal domains important for fusion triggering and metastability. J Virol. 2013;87(24): 13520-13531. http://dx.doi.org/10.1128/JVI.02123-13.
133. Brindley MA, Takeda M, Plattet P, Plemper RK. Triggering the measles virus membrane fusion machinery. Proc Natl Acad Sci USA. 2012;109(44): E3018-E3027. http://dx.doi.org/10.1073/pnas.1210925109.
134. Mahon PJ, Mirza AM, Musich TA, Iorio RM. Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin-neuraminidase protein: implications for the mechanism of fusion promotion. J Virol. 2008; 82(21): 10386-10396. http://dx.doi.org/10.1128/JVI.00581-08.
135. Zokarkar A, Connolly SA, Jardetzky TS, Lamb RA. Reversible inhibition of fusion activity of a paramyxovirus fusion protein by an engineered disulfide bond in the membrane-proximal external region. J Virol. 2012;86(22): 12397-12401. http://dx.doi.org/10.1128/JVI.02006-12.
136. Zokarkar A, Lamb RA. The paramyxovirus fusion protein C-terminal region: mutagenesis indicates an indivisible protein unit. J Virol. 2012;86(5): 2600-2609. http://dx.doi.org/10.1128/JVI.06546-11.
137. Donald JE, Zhang Y, Fiorin G, et al. Transmembrane orientation and possible role of the fusogenic peptide from parainfluenza virus 5 (PIV5) in promoting fusion. Proc Natl Acad Sci USA. 2011; 108(10): 3958-3963. http://dx.doi.org/10.1073/pnas.1019668108.
138. Porotto M, Rockx B, Yokoyama CC, et al. Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathog. 2010; 6(10): e1001168. http://dx.doi.org/10.1371/journal.ppat.1001168.
139. Welsch JC, Talekar A, Mathieu C, et al. Fatal measles infection prevented by brain-penetrant fusion inhibitors. J Virol. 2013;87(24): 13785-13794. http://dx.doi.org/10.1128/JVI.02436-13.
140. Pessi A, Langella A, Capitò E, et al. A general strategy to endow natural fusion-proteinderived peptides with potent antiviral activity. PLoS One. 2012;7(5): e36833. http://dx.doi.org/10.1371/journal.pone.0036833.
141. Chen L, Gorman JJ, McKimm-Breschkin J, et al. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure. 2001; 9(3): 255-266.
142. Palermo LM, Porotto M, Yokoyama CC, et al. Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. J Virol. 2009; 83(13): 6900-6908. http://dx.doi.org/10.1128/JVI.00475-09.
143. Farzan SF, Palermo LM, Yokoyama CC, et al. Premature activation of the paramyxovirus fusion protein before target cell attachment with corruption of the viral fusion machinery. J Biol Chem. 2011; 286(44): 37945-37954. http://dx.doi.org/10.1074/jbc.M111.256248.
144. Palmer SG, Porotto M, Palermo LM, Cunha LF, Greengard O, Moscona A. Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue. MBio. 2012;3(3): e00137. http://dx.doi.org/10.1128/mBio.00137-12.